文献速递肝病消化道肿瘤与早癌

靶向角鲨烯环氧酶可恢复代谢功能障碍相关脂肪性肝炎诱导的肝细胞癌中抗PD-1的疗效

Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
PubMed 文献 · Gut · 2024-11-11

本研究通过肝细胞特异性Sqle转基因和敲除小鼠及原位与人源化小鼠模型,发现角鲨烯环氧酶(SQLE)促进MASH-HCC肿瘤负荷并抑制CD8+ T细胞功能、富集Arg-1+髓源性抑制细胞。靶向SQLE(遗传敲除或药物抑制剂特比萘芬)可恢复MASH-HCC模型中抗PD-1治疗的疗效。

要点

  • 肝细胞特异性Sqle转基因小鼠MASH-HCC负荷显著增加,肿瘤浸润功能性IFN-γ+和Granzyme B+ CD8+ T细胞减少,Arg-1+ MDSCs富集。
  • SQLE通过驱动肿瘤微环境中胆固醇积累,诱导CD8+ T细胞线粒体功能障碍并激活MDSCs,从而促进免疫抑制。
  • 遗传敲除或药物抑制剂特比萘芬靶向SQLE可恢复MASH-HCC模型中抗PD-1治疗的疗效。

核心结论

  • SQLE通过减弱CD8+ T细胞功能和增强免疫抑制性MDSCs,在MASH-HCC中诱导抗肿瘤反应受损。
  • SQLE是增强MASH-HCC抗PD-1免疫治疗的有前景靶点。

研究设计与样本

  • 建立肝细胞特异性Sqle转基因(tg)和敲除小鼠,采用胆碱缺乏高脂饮食联合二乙基亚硝胺诱导MASH-HCC。
  • 在原位和人源化小鼠中确定SQLE功能。
  • 通过单细胞RNA测序和流式细胞术分析SQLE介导的MASH-HCC免疫景观改变。

主要发现

  • 肝细胞特异性Sqle tg小鼠MASH-HCC负荷较野生型同窝仔鼠显著增加,肿瘤浸润功能性IFN-γ+和Granzyme B+ CD8+ T细胞减少,Arg-1+ MDSCs富集。
  • 肝细胞特异性Sqle敲除抑制肿瘤生长,细胞毒性CD8+ T细胞增加,Arg-1+ MDSCs减少。
  • SQLE驱动的肿瘤微环境胆固醇积累是其影响CD8+ T细胞和MDSCs的基础;SQLE及其代谢物胆固醇通过诱导线粒体功能障碍损害CD8+ T细胞活性。
  • 体外胆固醇耗竭消除了SQLE过表达MASH-HCC细胞上清对CD8+ T细胞抑制和MDSC活化的影响,而胆固醇补充对经SQLE敲除上清处理的CD8+ T细胞和MDSCs具有相反作用。
  • 遗传敲除或药物抑制剂特比萘芬靶向SQLE可恢复MASH-HCC模型中抗PD-1治疗的疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Squalene epoxidase (SQLE) promotes metabolic dysfunction-associated steatohepatitis-associated hepatocellular carcinoma (MASH-HCC), but its role in modulating the tumour immune microenvironment in MASH-HCC remains unclear. DESIGN: We established hepatocyte-specific Sqle transgenic (tg) and knockout mice, which were subjected to a choline-deficient high-fat diet plus diethylnitrosamine to induce MASH-HCC. SQLE function was also determined in orthotopic and humanised mice. Immune landscape alterations of MASH-HCC mediated by SQLE were profiled by single-cell RNA sequencing and flow cytometry. RESULTS: Hepatocyte-specific Sqle tg mice exhibited a marked increase in MASH-HCC burden compared with wild-type littermates, together with decreased tumour-infiltrating functional IFN-γ+ and Granzyme B+ CD8+ T cells while enriching Arg-1+ myeloid-derived suppressor cells (MDSCs). Conversely, hepatocyte-specific Sqle knockout suppressed tumour growth with increased cytotoxic CD8+ T cells and reduced Arg-1+ MDSCs, inferring that SQLE promotes immunosuppression in MASH-HCC. Mechanistically, SQLE-driven cholesterol accumulation in tumour microenvironment underlies its effect on CD8+ T cells and MDSCs. SQLE and its metabolite, cholesterol, impaired CD8+ T cell activity by inducing mitochondrial dysfunction. Cholesterol depletion in vitro abolished the effect of SQLE-overexpressing MASH-HCC cell supernatant on CD8+ T cell suppression and MDSC activation, whereas cholesterol supplementation had contrasting functions on CD8+ T cells and MDSCs treated with SQLE-knockout supernatant. Targeting SQLE with genetic ablation or pharmacological inhibitor, terbinafine, rescued the efficacy of anti-PD-1 treatment in MASH-HCC models. CONCLUSION: SQLE induces an impaired antitumour response in MASH-HCC via attenuating CD8+ T cell function and augmenting immunosuppressive MDSCs. SQLE is a promising target in boosting anti-PD-1 immunotherapy for MASH-HCC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Wen J, Zhang X, Wong CC, et al. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma. Gut. 2024. PMID: 38744443. doi:10.1136/gutjnl-2023-331117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。